Published in

Wiley, Journal of Pathology, 5(250), p. 667-684, 2020

DOI: 10.1002/path.5406

Links

Tools

Export citation

Search in Google Scholar

The path to a better biomarker: application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers in breast cancer clinical trials and daily practice.

Journal article published in 2020 by Paula I Gonzalez-Ericsson, Anne Vincent-Salomon, Elisabeth S. Stovgaard, Luz F. Sua, Jodi M. Carter, Gonzalez Ericsson Pi, Emily Reisenbichler, Torsten O. Nielsen, Anne-Vibeke Laenkholm, Anne‐Vibeke Lænkholm, Stephen B. Fox, Zuzana Kos, Stovgaard Es, John Ms S. Bartlett, David L. Rimm and other authors.
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO